AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT02675452 · TERMINATED

Trial details

NCT number: NCT02675452
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Multiple Myeloma Relapsed or Refractory Acute Myeloid Leukemia

Start date: 2016-06-13
Primary completion: 2024-05-27
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.